GSK picks McCann to launch cervical cancer vaccine in India

MUMBAI - GlaxoSmithKline (GSK) has selected McCann Healthcare Worldwide to drive the launch of cervical cancer vaccine Cervarix in the Indian market, following a pitch that included JWT, Ogilvy & Mather Healthcare and Sudler & Hennessey.

by David Blecken